Paterson, David L

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 14,449

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 6,142

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 2,922

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases

Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

Cited by 512

The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.

Ulldemolins, M., Roberts, J. A., Rello, J., Paterson, D. L., & Lipman, J. (2011) · Clinical Pharmacokinetics

Antibiotics Pharmacokinetics and EfficacyProtein Interaction Studies and Fluorescence Analysis

Cited by 469

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial

Tong, S. Y. C., Lye, D. C., Yahav, D., Sud, A., Robinson, J. O., Nelson, J., Archuleta, S., Roberts, M. A., Cass, A., Paterson, D. L., et al. (2020) · JAMA

Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

Cited by 279

Health Risks of Flood Disasters

Paterson, D. L., Wright, H., & Harris, P. N. A. (2018) · Clinical Infectious Diseases

Disaster Response and ManagementClimate Change and Health Impacts

Cited by 274

Dosing guidance for intravenous colistin in critically-ill patients.

Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases

Antibiotics Pharmacokinetics and EfficacyAntibiotic Resistance in Bacteria

Cited by 262

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 192

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials

The LOVIT-COVID Investigators, O. B. O. T. C. C. C. T. G., Florescu, S., Stanciu, D., Zaharia, M., Kosa, A., Codreanu, D., Fareed, K., Kidwai, A., Kaye, C., Coutts, A., et al. (2023) · JAMA

Vitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies

Cited by 55

Clinical and cost implications of Biofire FilmArray® meningitis/encephalitis panel testing: a systematic review

Rafiei, N., Subedi, S., Harris, P. N., & Paterson, D. L. (2025) · Diagnostic Microbiology and Infectious Disease

Bacterial Infections and VaccinesBacterial Identification and Susceptibility Testing

Cited by 13